About Contact Us Careers
Sign In

In-vitro Diagnostics Market Analysis

  • Report ID: 1354
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

In-vitro Diagnostics Market Analysis

Product Type (Instruments, Reagents & Consumables)

The global in-vitro diagnostics market is segmented and analyzed for demand and supply by product type into reagents & kits, instruments, and services. The faster detection of chronic diseases and genetic disorders is most likely to drive the growth of this segment. Based on application, it is segmented into infectious diseases, cardiology, oncology, gastroenterology and others. The oncology segment is expected to grow in the forecast period, owing to the growing cases of cancer worldwide. According to the WHO data, over 10 million deaths were caused by cancer in 2020.

Our in-depth analysis of the global market includes the following segments:

     By Product Type
  • Instruments
  • Reagents & Consumables

      By Test
  • Immunodiagnostics
  • Clinical Chemistry
  • Molecular Diagnostics
  • Hematology 
  • Others

      By Application
  • Infectious Diseases
  • Cardiology
  • Oncology
  • Gastroenterology
  • Others
Get more information on this report: Request Free Sample PDF
Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar


  • Report ID: 1354
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of in-vitro diagnostics is assessed at USD 102.03 billion.

The in-vitro diagnostics market size was valued at USD 97.36 billion in 2024 and is likely to reach USD 201.17 billion by the end of 2037, expanding at around 6.1% CAGR during the forecast period i.e., between 2025-2037. Increasing awareness towards point-of-care testing from centralized testing, and increase in chronic and infectious diseases will impel the market growth.

North America industry is projected to account for largest revenue share by 2037, driven by the increasing requirement of genetic testing for personalized health care, diabetes, and cancer in the region.

The major players in the market include Abbott Laboratories, Roche Diagnostics, DiaSorin S. p. A., Johnson & Johnson corporation, Becton, Dickinson and Company, Siemens Healthineers, Danaher Corporations, Bio-Rad Laboratories, Thermo Fisher Scientific, Pfizer Inc.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample